Tate Simon 4
4 · Eliem Therapeutics, Inc. · Filed Jun 28, 2024
Insider Transaction Report
Form 4
Tate Simon
Director
Transactions
- Award
Stock Option (Right To Buy)
2024-06-26+10,000→ 10,000 totalExercise: $7.89Exp: 2034-06-25→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on the earlier of June 26, 2025 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date.